Prognostic utility of a multi-biomarker panel in patients with suspected myocardial infarction

Figures

• 

  Fig. 1. Univariable Cox Regression Analysis for the Prediction of 1-year MACE. Provided are the hazard ratios (HR) per standard deviation (SD) with respective 95% confidence intervals (CI) in ascending sequence from the top to the bottom for each biomarker in the univariable, age-/sex-adjusted Cox regression model for 1-year MACE. A2Macro alpha-2-macroglobulin; Apo apolipoprotein; CI confidence interval; CRP C-reactive protein; EN-RAGE extracellular newly identified receptor for advanced glycation end-products binding protein; FABP fatty acid–binding protein; HR hazard ratio; hs-cTnI high-sensitivity cardiac troponin I; KIM-1 kidney injury molecule–1; LOX-1 lectin-like oxidized low-density lipoprotein receptor 1; NT-proBNP N-terminal prohormone of brain natriuretic peptide; PAI-1 plasminogen activator inhibitor 1; PARC pulmonary and activation-regulated chemokine; RANTES T cell–specific protein RANTES; SD standard deviation; suPAR soluble urokinase-type plasminogen activator receptor; THP Tamm-Horsfall urinary glycoprotein; TIMP-1 tissue inhibitor ofmetalloproteinases 1; TM thrombomodulin; TNFR2 tumor necrosis factor receptor 2; TTR transthyretin; VCAM-1 vascular cell adhesion molecule–1